Preservation of lymphocyte immunophenotype and proliferative responses in cryopreserved peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected donors: implications for multicenter clinical trials. The ACTG Immunology Advanced Technology Laboratories.
Reimann KA, Chernoff M, Wilkening CL, Nickerson CE, Landay AL
Purpose
Conclusion
Studies (1)
Purpose
This study compared cell count, viability, and proliferative responsiveness of immune cells and subsets in freshly collected whole blood specimens, fresh Ficoll-isolated peripheral blood mononuclear cells (PBMC), and cryopreserved (frozen and thawed) PBMC. Biospecimens were collected from HIV-1 infected patients at nine participating institutions.
Summary of Findings
Percentages of major lymphoctye subsets (T-cell, B-cell, CD19+) were significantly impacted by both fresh Ficoll-isolation of PBMC and cryopreservation of PBMC, while the percentage of CD4+ was elevated in freshly Ficoll-isolated PBMC compared to fresh whole blood and cryopreserved PBMC. Percentages of CD3+ and CD8+ did not differ among differentially processed specimens. A reduction in CD62L staining intensity, and a lower percentage of CD38+ and HLA-DR+ cells were observed in freshly Ficoll-isolated PBMC and those that were cryopreserved compared to fresh whole blood specimens. However, proliferative response was retained in differentially processed specimens, with a <10% probability of loss due to cryopreservation.
Biospecimens
FluidBloodCellBloodPreservation Types
FrozenNone (Fresh)Diagnoses
AIDS/HIV-relatedPlatforms
Cell count/volumeImmunoassayCell count/volumeFlow cytometryCell count/volumeLight microscopyPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Blood and blood products Peripheral blood mononuclear cellsWhole bloodBiospecimen Preservation Type of fixation/preservation FrozenNone (fresh)Immunoassay Specific Targeted peptide/protein CD19CD28CD3CD38CD4CD45RACD62LCD8CD95HLA-DR